Utility of Clinical Risk Stratification in the Selection of Muscle-Invasive Bladder Cancer Patients for Neoadjuvant Chemotherapy: A Retrospective Cohort Study

Introduction: Level I evidence supports the use of cisplatin-based neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer prior to radical cystectomy (RC). On average, 30–40% of patients achieve a complete pathologic response (i.e., stage pT0) after receiving NAC. Some centers risk-strati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Bladder Cancer
Main Authors: von Rundstedt, Friedrich-Carl, Mata, Douglas A., Kryvenko, Oleksandr N., Shah, Anup A., Jhun, Iny, Lerner, Seth P.
Formato: Artigo
Idioma:Inglês
Publicado em: IOS Press 2017
Assuntos:
Research Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5271426/
https://ncbi.nlm.nih.gov/pubmed/28149933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/BLC-160062
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados